跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/PER-023-04
PER-023-04已完成未知

COMPARATIVE STUDY OF PHASE III RANDOMIZED, DOUBLE-BLIND TWO REGIMES OF DOSE OF MICAFUNGIN (FK463) VERSUS CASPOFUNGIN FOR THE TREATMENT OF CANDIDIASTIC ESOPHAGITIS

FUJISAWA HEALTH CARE INC,0 个研究点目标入组 0 人开始时间: 2004年5月6日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症

试验速览

阶段
未知
状态
已完成
发起方
研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • •Esophageal candidiasis confirmed by endoscopy
  • •Negative pregnancy test for female patients of childbearing potential

排除标准

  • •Pregnant or nursing female patient
  • •Evidence of liver disease
  • •Another active opportunistic fungal infection and/or receiving acute systemic therapy for an opportunistic fungal infection
  • •Concomitant esophagitis caused by herpes simplex virus or cytomegalovirus
  • •Received an oral or topical antifungal agent within 48 hours or a systemic antifungal agent within 72 hours of first dose of study drug
  • •Known to be non-responsive to therapy in any prior systemic antifungal clinical trail
  • •Experienced > 2 episodes of esophageal candidiasis requiring systemic antifungal therapy
  • •History of anaphylaxis attributed to echinocandin class of antifungals

研究者

发起方
FUJISAWA HEALTH CARE INC,

相似试验

已完成
不适用
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal CandidiasisCandidiasis-B37 CandidiasisB37
PER-026-04FUJISAWA HEALTH CARE INC,
已完成
不适用
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis-B379 Candidiasis, unspecifiedCandidiasis, unspecifiedB379
PER-024-04FUJISAWA HEALTH CARE INC,
已完成
不适用
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis-B379 Candidiasis, unspecifiedCandidiasis, unspecifiedB379
PER-046-04FUJISAWA HEALTH CARE INC,
已完成
不适用
Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis.-B379 Candidiasis, unspecifiedCandidiasis, unspecifiedB379
PER-055-03FUJISAWA HEALTH CARE INC,
已完成
不适用
COMPARATIVE TRIAL OF MICAFUNGIN VERSUS FLUCONAZOLE FOR TREATING ESOPHAGEAL CANDIDIASIS.-B379 Candidiasis, unspecifiedCandidiasis, unspecifiedB379
PER-048-03FUJISAWA HEALTH CARE INC,